A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS-102 in irinotecan-refractory metastatic colorectal cancer patients

Valerie Lee, Rose Parkinson, Marianna Zahurak, Leslie Cope, Andrea Cercek, Henk Verheul, Elske Gootjes, Heinz Josef Lenz, Syma Iqbal, Peter Jones, Stephen Baylin, Vandna Rami, Nita Ahuja, Anthony El Khoueiry, Nilofer S. Azad

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS-102 in irinotecan-refractory metastatic colorectal cancer patients'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science